Keyphrases
Recombinant Activated Factor VII (rFVIIa)
100%
Intracerebral Hemorrhage
100%
Spontaneous Intracerebral Hemorrhage
100%
Placebo
50%
Adverse Events
33%
Hemorrhage Volume
33%
Ultra-early
33%
Randomized Double-blind
16%
Placebo-controlled
16%
Safety Profile
16%
Improved Outcomes
16%
Computed Tomography
16%
Pulmonary Embolism
16%
Deep Vein Thrombosis
16%
Glasgow Coma Scale
16%
Cardiac Enzymes
16%
Basal Ganglia
16%
Edema
16%
Venous Disease
16%
Volume Ratio
16%
Cerebral Infarction
16%
Rebleeding
16%
Activated Factor VII
16%
Hematoma Growth
16%
Hemostatic Therapy
16%
Onset to Treatment
16%
Hematoma Expansion
16%
Ischemic ECG Changes
16%
Thromboembolic Adverse Events
16%
Consumption Coagulopathy
16%
NovoSeven
16%
Pharmacology, Toxicology and Pharmaceutical Science
Brain Hemorrhage
100%
Blood Clotting Factor 7
100%
Placebo
50%
Adverse Event
37%
Hematoma
25%
Thromboembolism
25%
Edema
12%
Deep Vein Thrombosis
12%
Lung Embolism
12%
Hemostatic Agent
12%
Recombinant Blood Clotting Factor 7a
12%
Brain Infarction
12%
Glasgow Coma Scale
12%
Disseminated Intravascular Clotting
12%
Diseases
12%
Neuroscience
Cerebral Hemorrhage
100%
Factor VII
100%
Placebo
50%
Hematoma
25%
Computed Tomography
12%
Basal Ganglia
12%
Deep Vein Thrombosis
12%
Cerebral Infarction
12%
Coagulopathy
12%
Pulmonary Embolism
12%
Recombinant Blood Clotting Factor 7a
12%
Glasgow Coma Scale
12%